CD86 and non-small cell lung carcinoma: Supporting this finding, multiplex immunofluorescence (mIF) staining of the formalin‐fixed paraffin‐embedded (FFPE) tissues collected from NSCLC patients showed a significant decrease in tumor‐infiltrating CD11c+HLA‐DR+, CD11c+CD86+cells and CD8+ lymphocytes cells in EGFR mutant patients compared to the WT (Figure 1d and Figure S2, Supporting Information).